Skillnaden mellan K2 och K3 regelverken : Vad tycker redovisningsexperter att K2-företagen bör välja när K-regelverken träder i kraft?

Autor: Josefsson, Pontus, Lejdström, Jesper

Sammanfattning Titel: Skillnaden mellan K2 och K3 regelverken.Vad tycker redovisningsexperter att K2-företagen bör välja när K-regelverken träder i kraft? Datum: 2011-06-09 Lärosäte: Mälardalens Högskola, Västerås Institution: Akademin fö

Externí odkaz: http://urn.kb.se/resolve?urn=urn:nbn:se:mdh:diva-12533

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Suicidal behavior in patients with severe mental disorders prior to and during the COVID-19 pandemic.

Autor: Mittendorfer-Rutz E; Department of Clinical Neuroscience, Division of Insurance Medicine, Karolinska Institutet, Stockholm, Sweden., Bergström J; Department of Clinical Neuroscience, Division of Insurance Medicine, Karolinska Institutet, Stockholm, Sweden., Josefsson P; Department of Clinical Neuroscience, Division of Insurance Medicine, Karolinska Institutet, Stockholm, Sweden., Taipale H; Department of Clinical Neuroscience, Division of Insurance Medicine, Karolinska Institutet, Stockholm, Sweden., Sijbrandij M; Department of Clinical, Neuro- and Developmental Psychology, VU University Amsterdam, WHO Collaborating Center for Research and Dissemination of Psychological Interventions, Amsterdam Public Health Research Institute, Amsterdam, the Netherlands., Witteveen A; Department of Clinical, Neuro- and Developmental Psychology, VU University Amsterdam, WHO Collaborating Center for Research and Dissemination of Psychological Interventions, Amsterdam Public Health Research Institute, Amsterdam, the Netherlands., Monzio Compagnoni M; Unit of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy.; National Centre for Healthcare Research and Pharmacoepidemiology, University of Milano-Bicocca, Milan, Italy., Lora A; National Centre for Healthcare Research and Pharmacoepidemiology, University of Milano-Bicocca, Milan, Italy.; Department of Mental Health and Addiction Services, ASST Lecco, Lecco, Italy., Felez-Nobrega M; Research and Development Unit, Parc Sanitari Sant Joan de Déu, Institut Sant Joan de Déu-CERCA, Sant Boi de Llobregat, Spain.; Centre for Biomedical Research on Mental Health (CIBERSAM), Barcelona, Spain., Haro JM; Research and Development Unit, Parc Sanitari Sant Joan de Déu, Institut Sant Joan de Déu-CERCA, Sant Boi de Llobregat, Spain.; Centre for Biomedical Research on Mental Health (CIBERSAM), Barcelona, Spain.; Departament de Medicina, Universitat de Barcelona, Barcelona, Spain., Melchior M; Equipe de Recherche en Epidémiologie Sociale, Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France., van der Waerden J; Equipe de Recherche en Epidémiologie Sociale, Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France., Gemes K; Department of Clinical Neuroscience, Division of Insurance Medicine, Karolinska Institutet, Stockholm, Sweden., Amin R; Department of Clinical Neuroscience, Division of Insurance Medicine, Karolinska Institutet, Stockholm, Sweden.; Division of Infectious Diseases, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.

Publikováno v: Psychological medicine [Psychol Med] 2024 Dec 16, pp. 1-9. Date of Electronic Publication: 2024 Dec 16.